223 related articles for article (PubMed ID: 37282486)
1. Phosphorylated S6K1 and 4E-BP1 play different roles in constitutively active Rheb-mediated retinal ganglion cell survival and axon regeneration after optic nerve injury.
Jiang J; Zhang L; Zou J; Liu J; Yang J; Jiang Q; Duan P; Jiang B
Neural Regen Res; 2023 Nov; 18(11):2526-2534. PubMed ID: 37282486
[TBL] [Abstract][Full Text] [Related]
2. The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration.
Yang L; Miao L; Liang F; Huang H; Teng X; Li S; Nuriddinov J; Selzer ME; Hu Y
Nat Commun; 2014 Nov; 5():5416. PubMed ID: 25382660
[TBL] [Abstract][Full Text] [Related]
3. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
Tee AR; Manning BD; Roux PP; Cantley LC; Blenis J
Curr Biol; 2003 Aug; 13(15):1259-68. PubMed ID: 12906785
[TBL] [Abstract][Full Text] [Related]
4. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.
Fingar DC; Richardson CJ; Tee AR; Cheatham L; Tsou C; Blenis J
Mol Cell Biol; 2004 Jan; 24(1):200-16. PubMed ID: 14673156
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
[TBL] [Abstract][Full Text] [Related]
6. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease.
Xu Y; Liu C; Chen S; Ye Y; Guo M; Ren Q; Liu L; Zhang H; Xu C; Zhou Q; Huang S; Chen L
Cell Signal; 2014 Aug; 26(8):1680-1689. PubMed ID: 24726895
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection of resveratrol against cadmium-poisoning acts through dual inhibition of mTORC1/2 signaling.
Liu C; Zhang R; Yang L; Ji T; Zhu C; Liu B; Zhang H; Xu C; Zhang N; Huang S; Chen L
Neuropharmacology; 2022 Nov; 219():109236. PubMed ID: 36049535
[TBL] [Abstract][Full Text] [Related]
8. Ca
Xia X; Shi C; Tsien C; Sun CB; Xie L; Luo Z; Bian M; Russano K; Thakur HS; Benowitz LI; Goldberg JL; Kapiloff MS
eNeuro; 2024 Mar; 11(3):. PubMed ID: 38548335
[TBL] [Abstract][Full Text] [Related]
9. Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis.
Zhou Q; Liu C; Liu W; Zhang H; Zhang R; Liu J; Zhang J; Xu C; Liu L; Huang S; Chen L
Toxicol Sci; 2015 Jan; 143(1):81-96. PubMed ID: 25304210
[TBL] [Abstract][Full Text] [Related]
10. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
11. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
Oshiro N; Takahashi R; Yoshino K; Tanimura K; Nakashima A; Eguchi S; Miyamoto T; Hara K; Takehana K; Avruch J; Kikkawa U; Yonezawa K
J Biol Chem; 2007 Jul; 282(28):20329-39. PubMed ID: 17517883
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen peroxide impairs insulin-stimulated assembly of mTORC1.
Zhang L; Kimball SR; Jefferson LS; Shenberger JS
Free Radic Biol Med; 2009 Jun; 46(11):1500-9. PubMed ID: 19281842
[TBL] [Abstract][Full Text] [Related]
13. Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling.
Vigneswara V; Akpan N; Berry M; Logan A; Troy CM; Ahmed Z
Brain; 2014 Jun; 137(Pt 6):1656-75. PubMed ID: 24727569
[TBL] [Abstract][Full Text] [Related]
14. Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth.
Douglas MR; Morrison KC; Jacques SJ; Leadbeater WE; Gonzalez AM; Berry M; Logan A; Ahmed Z
Brain; 2009 Nov; 132(Pt 11):3102-21. PubMed ID: 19783665
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.
Dodd KM; Yang J; Shen MH; Sampson JR; Tee AR
Oncogene; 2015 Apr; 34(17):2239-50. PubMed ID: 24931163
[TBL] [Abstract][Full Text] [Related]
16. Evidence that S6K1, but not 4E-BP1, mediates skeletal muscle pathology associated with loss of A-type lamins.
Liao CY; Anderson SS; Chicoine NH; Mayfield JR; Garrett BJ; Kwok CS; Academia EC; Hsu YM; Miller DM; Bair AM; Wilson JA; Tannady G; Stewart EM; Adamson SS; Wang J; Withers DJ; Kennedy BK
Cell Discov; 2017; 3():17039. PubMed ID: 29736257
[TBL] [Abstract][Full Text] [Related]
17. Identification of a conserved motif required for mTOR signaling.
Schalm SS; Blenis J
Curr Biol; 2002 Apr; 12(8):632-9. PubMed ID: 11967149
[TBL] [Abstract][Full Text] [Related]
18. Regenerative Responses and Axon Pathfinding of Retinal Ganglion Cells in Chronically Injured Mice.
Yungher BJ; Ribeiro M; Park KK
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1743-1750. PubMed ID: 28324115
[TBL] [Abstract][Full Text] [Related]
19. The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury.
Al-Ali H; Ding Y; Slepak T; Wu W; Sun Y; Martinez Y; Xu XM; Lemmon VP; Bixby JL
J Neurosci; 2017 Jul; 37(30):7079-7095. PubMed ID: 28626016
[TBL] [Abstract][Full Text] [Related]
20. Effects of siRNA-Mediated Knockdown of GSK3β on Retinal Ganglion Cell Survival and Neurite/Axon Growth.
Ahmed Z; Morgan-Warren PJ; Berry M; Scott RAH; Logan A
Cells; 2019 Aug; 8(9):. PubMed ID: 31443508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
